Events & Presentations
SOLUTIONS with/in/sight: Cells in the City; by The Koch Institute at MIT
November 29, 2017,
They may not have won seven Emmys and eight Golden Globes; yet projects from the Koch Institute Frontier Research Program have hit the big time! Join MIT’s Koch Institute for Integrative Cancer Research for an evening of presentations and conversation about two daring cancer research projects turned start-up, breaking new ground as they enter the marketplace and move into the clinic. SQZ Biotechnologies is disrupting both cell membranes and biopharma with its cell-squeezing technology for cell therapies, including promising new-to-immunotherapy approaches. Lumicell illuminates cancer at the cellular level, for real-time action during surgery and forward-thinking action in industry. Hear from lead scientists and their corporate partners about their journeys from bench to biotech, and find out how grassroots funding from the Koch Institute’s signature Frontier Research Program helped propel these high-risk ideas into high-reward technology. 6:00 to 8:30 PM
Institute for Biomedical Entrepreneurship (IBE) Certificate Session
September 13 - 17, 2017
The IBE brings the specialized know-how and the funding required for translational development success. In addition, the IBE provides biomedical researchers and innovators with educational programs and hands-on training that will help them become more aware of how to make their discoveries end up in the marketplace. Kelly Londy, CEO of Lumicell, will present as a guest faculty member in a session titled “Scientific Validation, Scientific Replication and the Commercial Pathway” on Friday, September 15 from 1:45 to 3:00 p.m.
The 2nd International Prostate Cancer Symposium and Inaugural World Congress of Urologic Oncology
September 6-9, 2017
The Mount Sinai Urology Department will host a live interactive state-of-the-art educational symposium. The program will include 3D demonstrations of the latest robotic surgery techniques for prostate, kidney and bladder cancer. Directed by the world’s leading robotic experts and taught by an internationally renowned faculty. Format includes point – counterpoint debates, didactic lectures and abstract presentations. Lumicell will have a booth at this event.
The Convergence of Medical Devices & Drugs: The Future of Combination Products
May 12, 2017
Combination products are essential tools for patient care and continue to be an area of active and exciting development. From diffusion based polymer systems to complex delivery devices utilizing diagnostic sensors and sophisticated control systems for precise and timely delivery of life-saving agents, a diverse set of scientific and engineering disciplines are being brought to bear within this space. However, combination products involve components normally developed under different types of regulations, design criteria and controls. This symposium will explore many of the diverse aspects impacting combination products. W. David Lee, President of Lumicell, will be the Keynote Speaker.
San Antonio Breast Cancer Symposium
December 6-10, 2016
This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. Lumicell will have a booth at this event.
The American Society of Breast Surgeons 17th Annual Meeting
April 15, 2016
Collaborators from the Breast Program at Massachusetts General Hospital presented a poster based on the clinical study titled "Feasibility of the LUM imaging system for real-time, intraoperative detection of residual breast cancer in lumpectomy cavity margins."
World Medical Innovation Forum
April 25-27, 2016
Breakthrough Devices to Treat Cancer - The increasing demand for early diagnosis of cancer and the growing prevalence of metastatic brain, lung, breast, prostate and other cancers is driving the oncology device market. Our experts zero in on innovative technologies that will address challenges in cancer surgery and pain management.
Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity margins using the LUM Imaging System: Results of a feasibility study
Feasibility of the LUM Imaging System for real-time, intraoperative detection of residual breast cancer in lumpectomy cavity marginsView Poster